Reference Genome Database News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Reference Genome Database. Real-time updates on events, politics, business and more.

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma

April 12, 2023

Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway

United States United Kingdom Ro Gardner Tim Sharpington Sanger Institute Ip Group

Source: finanznachrichten.de

Microbiotica Announces Transition of Leadership

November 29, 2022

Co-founder and CEO Mike Romanos steps down after six years to take up role of Associate Dean of Enterprise in the Faculty of Medicine at Imperial College Tim Sharpington, Microbiotica COO

United Kingdom City Of Giulia Lasagni Batoul Ali Gordon Dougan Tim Sharpington Trevor Lawley

Source: finanznachrichten.de

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics

March 7, 2022

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics - read this article along with other careers information, tips and advice on BioSpace

United States Hong Kong United Kingdom City Of Sam Williams Carl Johan Spak

Source: biospace.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Reference Genome Database News Today

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma

Microbiotica Announces Transition of Leadership

Microbiotica Raises &#xA3;50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics

Explore More Categories

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics